. AEs for Psychiatric Disorders by Decreasing Frequency Multiple Dose Studies in Healthy Subjects A TEAE is generally defined as an adverse event that begins within 30 days after dosing with perampanel/placebo or an ongoing event that increases in severity after dosing with perampanel/placebo. Full details are given in the SAP. For each row category, a subject with two or more adverse events in the category is counted only once. N=number of subjects receiving the dose at anytime in the study (a) Actual dose at onset of the first occurrence of the TEAE within each dose group. (b) MedDRA preferred terms are sorted in descending order of frequency in the total column.
. AEs for Psychiatric Disorders by Decreasing Frequency Multiple Dose Studies in Healthy Subjects A TEAE is generally defined as an adverse event that begins within 30 days after dosing with perampanel/placebo or an ongoing event that increases in severity after dosing with perampanel/placebo. Full details are given in the SAP. For each row category, a subject with two or more adverse events in the category is counted only once. N=number of subjects receiving the dose at anytime in the study (a) Actual dose at onset of the first occurrence of the TEAE within each dose group. (b) MedDRA preferred terms are sorted in descending order of frequency in the total column.
auspar-perampanel-141014-cer.docx